EP1916301 - METHOD FOR EVALUATING COMPOUND USING MOLECULE ON THE RB PATHWAY AS INDEX AND MOLECULAR DIAGNOSTIC METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.02.2010 Database last updated on 13.11.2024 | Most recent event Tooltip | 12.02.2010 | Application deemed to be withdrawn | published on 17.03.2010 [2010/11] | Applicant(s) | For all designated states BANYU PHARMACEUTICAL CO., LTD. Kitanomaru Square 1-13-12, Kudan-kita Chiyoda-ku Tokyo 102-8667 / JP | [2008/18] | Inventor(s) | 01 /
EGUCHI, Tomohiro, c/o Banyu Pharmaceutical Co., Ltd. c/o Tsukuba Research Institute, 3, Okubo Tsukuba-shi, Ibaraki, 300-2611 / JP | 02 /
KOTANI, Hidehito, c/o Banyu Pharmaceutical Co., Ltd. c/o Tsukuba Research Institute, 3, Okubo Tsukuba-shi, Ibaraki, 300-2611 / JP | [2008/18] | Representative(s) | Hussain, Deeba Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | [N/P] |
Former [2008/18] | Hussain, Deeba Merck & Co., Inc. Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | Application number, filing date | 06782726.1 | 08.08.2006 | [2008/18] | WO2006JP315992 | Priority number, date | JP20050232971 | 11.08.2005 Original published format: JP 2005232971 | [2008/18] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007018309 | Date: | 15.02.2007 | Language: | JA | [2007/07] | Type: | A1 Application with search report | No.: | EP1916301 | Date: | 30.04.2008 | Language: | EN | [2008/18] | Search report(s) | International search report - published on: | JP | 15.02.2007 | (Supplementary) European search report - dispatched on: | EP | 03.03.2009 | Classification | IPC: | C12N15/09, C12Q1/02, C12Q1/68, G01N33/15, G01N33/50, A61K45/00, A61P35/00 | [2008/18] | CPC: |
G01N33/68 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
C12Q1/6886 (EP);
G01N33/5008 (EP);
G01N33/5011 (EP);
G01N33/502 (EP);
G01N33/5091 (EP);
| Designated contracting states | CH, DE, FR, GB, LI [2008/21] |
Former [2008/18] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERFAHREN ZUR BEWERTUNG EINER VERBINDUNG UNTER VERWENDUNG EINES MOLEKÜLS AUF DEM RB-WEG ALS INDEX SOWIE MOLEKULARDIAGNOSTISCHES VERFAHREN | [2008/18] | English: | METHOD FOR EVALUATING COMPOUND USING MOLECULE ON THE RB PATHWAY AS INDEX AND MOLECULAR DIAGNOSTIC METHOD | [2008/18] | French: | PROCEDED EVALUATION D UN COMPOSE A L AIDE D UNE MOLECULE SUR LE TRAJET RB COMME INDICE ET PROCEDEDE DIAGNOSTIC MOLECULAIRE | [2008/18] | Entry into regional phase | 13.02.2008 | Translation filed | 11.03.2008 | National basic fee paid | 11.03.2008 | Search fee paid | 11.03.2008 | Designation fee(s) paid | 11.03.2008 | Examination fee paid | Examination procedure | 13.02.2008 | Amendment by applicant (claims and/or description) | 11.03.2008 | Examination requested [2008/18] | 12.03.2008 | Loss of particular rights, legal effect: designated state(s) | 21.04.2008 | Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CY, CZ, DK, EE, ES, FI, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | 08.05.2009 | Despatch of a communication from the examining division (Time limit: M04) | 19.09.2009 | Application deemed to be withdrawn, date of legal effect [2010/11] | 23.10.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/11] | Fees paid | Renewal fee | 01.09.2008 | Renewal fee patent year 03 | 31.08.2009 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9824935 (UROCOR INC [US], et al) [X] 6-9 * figure 1; example 5 *; | [X]US2003096781 (MASOOD RIZWAN [US], et al) [X] 6-9 * figures 1,4; examples 1,13 *; | [X] - INOUE KEIJI ET AL, "Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer", CANCER RESEARCH, (200004), vol. 60, no. 8, ISSN 0008-5472, pages 2290 - 2299, XP002515599 [X] 1-4 * the whole document * | [XY] - BAR-ELI MENASHE, "Role of interleukin-8 in tumor growth and metastasis of human melanoma", PATHOBIOLOGY, KARGER, BASEL, CH, (19990101), vol. 67, no. 1, ISSN 1015-2008, pages 12 - 18, XP009112337 [X] 1-4 * the whole document * [Y] 10-12 DOI: http://dx.doi.org/10.1159/000028045 | [XY] - ZHANG HONGQUAN ET AL, "Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression", CELL GROWTH AND DIFFERENTIATION, (199907), vol. 10, no. 7, ISSN 1044-9523, pages 457 - 465, XP009112360 [X] 4 * the whole document * * figure 3 * [Y] 10-12 | [X] - REN YI ET AL, "Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 DEC 2003, (20031201), vol. 9, no. 16 Pt 1, ISSN 1078-0432, pages 5996 - 6001, XP002515601 [X] 6-9 * figures 1,2; table 3 * | [X] - MAIE JOHN A R ST ET AL, "Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma", ARCHIVES OF OTOLARYNGOLOGY HEAD AND NECK SURGERY, AMERICAN MEDICAL ASSOCIATION, US, (20040801), vol. 130, no. 8, ISSN 0886-4470, pages 929 - 935, XP002448845 [X] 6-9 * figures 1,3 * DOI: http://dx.doi.org/10.1001/archotol.130.8.929 |